
IRRAF
Healthcare · Medical Devices · $421.3M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 22, 2022 | Before the open | — | -0.05 | — |
| Apr 27, 2022 | Before the open | — | -0.04 | — |
| Feb 16, 2022 | Before the open | — | -0.19 | — |
| Nov 9, 2021 | Before the open | — | -0.11 | — |
| Aug 26, 2021 | Before the open | — | -0.14 | — |
| May 4, 2021 | Before the open | -0.19 | -0.20 | -5.3% |
| Feb 16, 2021 | Before the open | -0.15 | -0.19 | -26.7% |
| Nov 10, 2020 | Before the open | -0.18 | -0.16 | +11.1% |
| Aug 27, 2020 | Before the open | -0.54 | -0.55 | -1.9% |
| May 14, 2020 | Before the open | -1.25 | -1.12 | +10.4% |
| Feb 14, 2020 | Before the open | -1.33 | -1.20 | +9.8% |
| Nov 14, 2019 | Before the open | -1.37 | -1.17 | +14.6% |
| Aug 29, 2019 | Before the open | -1.50 | -1.46 | +2.7% |
IRRAS AB (publ), a medical device company, focuses on the delivery of medical solutions to enhance the lives of critically ill patients worldwide. It designs, develops, and commercializes neurocritical care products that transform patient outcomes and addresses complications associated with current treatment methodologies. The company offers IRRAflow, an irrigating intracranial drainage system that combines…
| May 7, 2019 | Before the open | 0.00 | -0.17 | — |
| Feb 14, 2019 | Before the open | 0.00 | -0.17 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.24 | — |
| Sep 30, 2018 | Time not confirmed | 0.00 | -0.20 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.14 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.09 | — |